{
    "eid": "2-s2.0-85106401918",
    "title": "Systematic review and practical guidance on the use of topical calcipotriol and topical calcipotriol with betamethasone dipropionate as long-term therapy for mild-to-moderate plaque psoriasis",
    "cover-date": "2021-07-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Dermatology",
            "@code": "2708",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "betamethasone dipropionate",
        "calcipotriol",
        "long-term care",
        "psoriasis",
        "topical administration"
    ],
    "authors": [
        "Yi Zhao",
        "Akihiko Asahina",
        "Pravit Asawanonda",
        "Ma Lorna Frez",
        "Shinichi Imafuku",
        "Dong Hyun Kim",
        "Colin Theng",
        "Liangchun Wang",
        "Jiang An Zhang",
        "Sameer Zimmo"
    ],
    "citedby-count": 4,
    "ref-count": 52,
    "ref-list": [
        "Psoriasis: a mixed autoimmune and autoinflammatory disease",
        "Pathogenesis and clinical features of psoriasis",
        "The importance of early treatment in psoriasis and management of disease progression",
        "Clinical goals and barriers to effective psoriasis care",
        "Treatment goals in psoriasis from a patient perspective: a qualitative study",
        "Psoriasis: which therapy for which patient: psoriasis comorbidities and preferred systemic agents",
        "Combining topical psoriasis treatment to enhance systemic and phototherapy: a review of the literature",
        "Back to the future: a new topical approach for mild-to-moderate psoriasis",
        "Combination, rotational, and sequential therapies",
        "Prevalence of psoriasis among adults in the U.S.: 2003\u20132006 and 2009\u20132010 National Health and Nutrition Examination Surveys",
        "Long-term adherence to topical psoriasis treatment can be abysmal: a 1-year randomized intervention study using objective electronic adherence monitoring",
        "Topical long-term therapy of psoriasis with vitamin D(3) analogues, corticosteroids and their two compound formulations: position paper on evidence and use in daily practice",
        "Treatment of psoriasis vulgaris with the two-compound product calcipotriol/betamethasone dipropionate followed by different formulations of calcipotriol",
        "The DESIRE study: psoriasis patients\u2019 satisfaction with topical treatment using a fixed combination of calcipotriol and betamethasone dipropionate in daily clinical practice",
        "A new calcipotriol/betamethasone formulation with rapid onset of action was superior to monotherapy with betamethasone dipropionate or calcipotriol in psoriasis vulgaris",
        "Scalp psoriasis: topical calcipotriol 50 micrograms/g/ml solution vs. betamethasone valerate 1% lotion",
        "Short- and long-term safety assessment of a two-compound ointment containing calcipotriene/betamethasone dipropionate (Taclonex/Daivobet/Dovobet ointment): hypothalamic-pituitary-adrenal axis function in patients with psoriasis vulgaris",
        "A comparison of tazarotene 0.1% gel once daily plus mometasone furoate 0.1% cream once daily versus calcipotriene 0.005% ointment twice daily in the treatment of plaque psoriasis",
        "Proactive treatment with calcipotriol reduces recurrence of plaque psoriasis",
        "A randomized, multicenter study of calcipotriene ointment and clobetasol propionate foam in the sequential treatment of localized plaque-type psoriasis: short- and long-term outcomes",
        "A 52-week randomized safety study of a calcipotriol/betamethasone dipropionate two-compound product (Dovobet/Daivobet/Taclonex) in the treatment of psoriasis vulgaris",
        "Efficacy results of a 52-week, randomised, double-blind, safety study of a calcipotriol/betamethasone dipropionate two-compound product (Daivobet/Dovobet/Taclonex) in the treatment of psoriasis vulgaris",
        "Double-blind, right/left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris",
        "Efficacy of once-daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris",
        "Optimal maintenance treatment with calcipotriol/betamethasone dipropionate gel in Korean patients with psoriasis vulgaris: a multicentre randomized, controlled clinical trial",
        "A study of the safety and efficacy of calcipotriol and betamethasone dipropionate scalp formulation in the long-term management of scalp psoriasis",
        "Treatment of paediatric scalp psoriasis with calcipotriene/betamethasone dipropionate scalp formulation: effectiveness, safety and influence on children's quality of life in daily practice",
        "A Topical Treatment Optimization Programme (TTOP) improves clinical outcome for calcipotriol/betamethasone gel in psoriasis: results of a 64-week multinational randomized phase IV study in 1790 patients (PSO-TOP)",
        "Efficacy of a fixed combination of calcipotriol/betamethasone dipropionate topical gel in adult patients with mild to moderate psoriasis: blinded interim analysis of a phase IV, multicenter, randomized, controlled, prospective study",
        "Comparison of calcipotriol monotherapy and a combination of calcipotriol and betamethasone valerate after 2 weeks\u2019 treatment with calcipotriol in the topical therapy of psoriasis vulgaris: a multicentre, double-blind, randomized study",
        "Efficacy, safety and quality of life of calcipotriol/betamethasone dipropionate (Dovobet) versus calcipotriol (Daivonex) in the treatment of psoriasis vulgaris: a randomized, multicentre, clinical trial",
        "Efficacy and maintenance strategies of two-compound formulation calcipotriol and betamethasone dipropionate gel (Xamiol(R) gel) in the treatment of scalp psoriasis: results from a study in 885 patients",
        "Topical nicotinamide in combination with calcipotriol for the treatment of mild to moderate psoriasis: a double-blind, randomized, comparative study",
        "Calcipotriol/betamethasone dipropionate ointment in mild-to-moderate paediatric psoriasis: long-term daily clinical practice data in a prospective cohort",
        "Use of calcipotriene cream (Dovonex cream) following acute treatment of psoriasis vulgaris with the calcipotriene/betamethasone dipropionate two-compound product (Taclonex): a randomized, parallel-group clinical trial",
        "New treatment regimen with calcipotriol/betamethasone ointment on psoriasis vulgaris of stationary stage",
        "Long-term treatment of chronic plaque psoriasis with calcipotriol",
        "Clinical observation of sequential therapy of calcipotriol betamethasone ointment combined with calcipotriol ointment in the treatment of psoriasis vulgaris (Chinese language)",
        "A study of the long-term efficacy and safety of a calcipotriol hydrate/betamethasone dipropionate ester fixed dose combination product in patients with psoriasis vulgaris (Japanese language)",
        "Calcipotriol betamethasone ointment combined with calcipotriol ointment for the treatment of psoriasis vulgaris (Chinese language)",
        "The efficacy of calcipotriol betamethasone ointment in maintenance treatment of mild to moderate psoriasis vulgaris (Chinese language)",
        "Therapeutic effect of calcipotriol betamethasone cream and calcipotriol ointment on psoriasis (Chinese language)",
        "Therapeutic effect of calcipotriol betamethasone ointment as maintenance treatment for mild-to-moderate psoriasis (Chinese language)",
        "Effects of calcipotriol betamethasone cream and calcipotriol ointment on plaque psoriasis (Chinese language)",
        "Therapeutic effect of calcipotriol betamethasone ointment as maintenance treatment of mild to moderate psoriasis vulgaris (Chinese language)",
        "The sequential therapy can rapidly improve psoriasis, lower medical cost, reduce glucocorticoid-induced adverse reactions (Chinese language)",
        "Evaluation of application effect of calcipotriol betamethasone ointment in the maintenance treatment of psoriasis (Chinese language)",
        "Sequential use of calcipotriol betamethasone ointment and calcipotriol ointment for psoriasis (Chinese language)",
        "Efficacy and safety evaluation of calcipotriol betamethasone ointment in the maintenance treatment of psoriasis vulgaris (Chinese language)",
        "Asian consensus on assessment and management of mild to moderate plaque psoriasis with topical therapy",
        "Assessment of \"corticophobia\" as an indicator of non-adherence to topical corticosteroids: a pilot study"
    ],
    "affiliation": [
        {
            "affiliation-city": "Zhengzhou",
            "@id": "60102075",
            "affilname": "First Affiliated Hospital of Zhengzhou University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60102075",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Manila",
            "@id": "60071449",
            "affilname": "University of the Philippines College of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60071449",
            "affiliation-country": "Philippines"
        },
        {
            "affiliation-city": "Fukuoka",
            "@id": "60031720",
            "affilname": "Fukuoka University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031720",
            "affiliation-country": "Japan"
        },
        {
            "affiliation-city": "Tokyo",
            "@id": "60031615",
            "affilname": "The Jikei University School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031615",
            "affiliation-country": "Japan"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Beijing",
            "@id": "60025278",
            "affilname": "Tsinghua University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60025278",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Guangzhou",
            "@id": "60021182",
            "affilname": "Sun Yat-Sen University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60021182",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Pocheon",
            "@id": "60005389",
            "affilname": "College of Medicine, Pochon CHA University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005389",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Jeddah",
            "@id": "60004582",
            "affilname": "King Abdulaziz University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60004582",
            "affiliation-country": "Saudi Arabia"
        },
        {
            "affiliation-city": "Singapore City",
            "@id": "100475399",
            "affilname": "Mt Alvernia Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/100475399",
            "affiliation-country": "Singapore"
        }
    ],
    "funding": [
        "Johnson and Johnson Philippines Inc.",
        "Pfizer",
        "Novartis",
        "Kyowa Kirin",
        "LEO Pharma"
    ]
}